AVELUMAB, Erbitux 5 mg/mL solution for infusion
AVEC-119
Phase 2 small_molecule active
Quick answer
AVELUMAB, Erbitux 5 mg/mL solution for infusion for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active